All about COVID-19

How bats harbour several viruses yet not get sick

Bats serves as natural host for numerous viruses including Ebola virus, Nipah virus, coronaviruses such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and the 2019 novel coronovirus.   | Photo Credit: S.Thanthoni

Bats serves as natural hosts for numerous viruses including Ebola virus, Nipah virus, coronaviruses such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and the 2019 novel coronavirus that has infected nearly 10,000 people and killed over 200 others. Even as these viruses cause harm in humans, they rarely if at all cause any harmful effects in bats. This is the case even when the viral load is extremely high in bats.

A study carried out last year and published in the journal Nature Microbiology revealed the mechanism responsible for bats to harbour numerous viruses without themselves getting affected and also live long. Compared with terrestrial mammals, bats have longer lifespan.

The reason why bats can harbour these viruses without getting affected is simply because bats can avoid excessive virus-induced inflammation, which often causes severe diseases in animals and people infected with viruses.

When pathogens infect humans and mice, the immune system gets activated and typical inflammatory response to fight the microbes is seen. While controlled inflammatory response to fight infection helps keep humans healthy, it can contribute to the damage caused by infectious diseases, and also age-related diseases when the inflammatory response becomes excessive.

Watch | Bats and the novel coronavirus

In complete contrast, the researchers found that the inflammatory response is dampened in bats immaterial of the variety of viruses that are present and the viral load. The researchers from Duke-NUS Medical School, Singapore used three different viruses — Melaka virus, MERS coronavirus and influenza A virus — and tested the responses of immune cell and other cells (peripheral blood mononuclear cells and bone-marrow derived macrophages) of bats, mice and humans to these viruses. While inflammation was high in the case of humans and mice, it was significantly reduced in bats immune cells.

“This supports an enhanced innate immune tolerance rather than an enhanced antiviral defence in bats,” they write. “This may also contribute to our understanding of the role of the inflammation in disease tolerance in bats as reservoir hosts” they say. This is in complete contrast to what is seen in mice and humans for disease-causing zoonotic viruses.

The researchers found that significantly reduced inflammation in bats was because activation of an important protein — NLRP3 — that recognises both cellular stress and viral/bacterial infections was significantly dampened in bat immune cells.

Studying further, the researchers found that reduced activation of the NLRP3 protein was in turn due to impaired production of mRNA (transcript). Since mRNA production is impaired the NLRP3 protein production gets compromised leading to less amount of the protein being produced. But this was not the case with mice and humans — there was no impairment to mRNA production so the NLRP3 protein was unaffected.

The NLRP3 protein is found as four variants in bats. The researchers found that the function of all the four variants in bats was dampened compared with human NLRP3. To test if their finding on NLRP3 holds true in evolutionally distant bats, the researchers studied two very distinct species of bats — Pteropus alecto, which is a large fruit bat known as the Black Flying Fox, and Myotis davadii, a tiny vesper bat from China. The variations have been found to be genetically conserved through evolution.

Further analysis comparing 10 bat and 17 non-bat mammalian NLRP3 gene sequences confirmed that these adaptations appear to be bat-specific.

This article is closed for comments.
Please Email the Editor

Printable version | Mar 7, 2021 8:03:05 AM | https://www.thehindu.com/sci-tech/science/how-bats-harbour-several-viruses-yet-not-get-sick/article30711334.ece

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
You are reading
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story